Capital Advisors Ltd’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $413K | Sell |
1,018
-193
| -16% | -$78.3K | 0.05% | 186 |
|
|
2025
Q1 | $603K | Buy |
1,211
+2
| +0.2% | +$996 | 0.08% | 139 |
|
|
2024
Q4 | $629K | Sell |
1,209
-26
| -2% | -$13.5K | 0.08% | 137 |
|
|
2024
Q3 | $764K | Buy |
1,235
+17
| +1% | +$10.5K | 0.09% | 122 |
|
|
2024
Q2 | $674K | Buy |
1,218
+6
| +0.5% | +$3.32K | 0.09% | 128 |
|
|
2024
Q1 | $704K | Buy |
1,212
+28
| +2% | +$16.3K | 0.09% | 124 |
|
|
2023
Q4 | $628K | Sell |
1,184
-8
| -0.7% | -$4.24K | 0.09% | 127 |
|
|
2023
Q3 | $603K | Buy |
1,192
+42
| +4% | +$21.2K | 0.09% | 127 |
|
|
2023
Q2 | $600K | Buy |
1,150
+309
| +37% | +$161K | 0.09% | 131 |
|
|
2023
Q1 | $485K | Sell |
841
-244
| -22% | -$141K | 0.08% | 136 |
|
|
2022
Q4 | $455K | Buy |
1,085
+265
| +32% | +$111K | 0.08% | 145 |
|
|
2022
Q3 | $416K | Buy |
820
+38
| +5% | +$19.3K | 0.08% | 143 |
|
|
2022
Q2 | $425K | Buy |
782
+68
| +10% | +$37K | 0.08% | 146 |
|
|
2022
Q1 | $422K | Buy |
714
+143
| +25% | +$84.5K | 0.07% | 154 |
|
|
2021
Q4 | $381K | Buy |
571
+155
| +37% | +$103K | 0.06% | 166 |
|
|
2021
Q3 | $238K | Buy |
416
+336
| +420% | +$192K | 0.04% | 191 |
|
|
2021
Q2 | $40K | Hold |
80
| – | – | 0.01% | 329 |
|
|
2021
Q1 | $37K | Buy |
+80
| New | +$37K | 0.01% | 316 |
|
|
2020
Q2 | – | Sell |
-40
| Closed | -$11K | – | 478 |
|
|
2020
Q1 | $11K | Hold |
40
| – | – | ﹤0.01% | 359 |
|
|
2019
Q4 | $13K | Hold |
40
| – | – | ﹤0.01% | 335 |
|
|
2019
Q3 | $12K | Sell |
40
-100
| -71% | -$30K | ﹤0.01% | 342 |
|
|
2019
Q2 | $41K | Buy |
140
+100
| +250% | +$29.3K | 0.01% | 297 |
|
|
2019
Q1 | $11K | Hold |
40
| – | – | ﹤0.01% | 364 |
|
|
2018
Q4 | $9K | Buy |
+40
| New | +$9K | ﹤0.01% | 382 |
|